Researchers have developed a groundbreaking blood test using Fourier Transform Infrared (FT-IR) microspectroscopy to detect a single lung cancer cell. This innovative technique identifies the unique ...

Researchers are studying tests called liquid biopsies, which can provide vital information about cancer genes using only a blood sample. A blood test to find cancer even before it shows any symptoms ...

TEXAS – A new wave of blood tests is changing how doctors detect cancer. These tests can find signs of cancer early, sometimes before symptoms appear, giving patients a better chance at successful ...

For years, it has been one of the most tantalizing ideas in medicine: One day, a simple blood test will detect nascent cancers — allowing doctors to intervene when tumors may be easier to treat. A ...

A blood test for more than 50 types of cancer could significantly boost early detection and speed up diagnosis, according to a new study. Made by U.S. pharmaceutical company Grail, the Galleri test ...

A Bay Area biotech company says its groundbreaking blood test can detect more than 50 cancers. Early detection can improve cancer outcomes and can save lives. Cancer is the second leading cause of ...

In the spring of 2021, the cancer field was abuzz over research that suggested a simple early-detection blood test could find dozens of different cancers, including many for which there is no routine ...

Free-floating DNA carrying cancerous mutations was detected in blood three years before any other signs of cancer appeared. If approved as a test, doctors might detect cancers sooner and treat them ...

"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...

SEATTLE — Doctors use blood tests to figure out cholesterol levels, blood sugar, and certain infections. But what if there's a blood test for cancer? The technology for a test like this has been ...

Roche has claimed the exclusive international rights to Freenome’s multiomic cancer screening approaches, toward the goal of developing blood testing kits for markets outside the U.S. The licensing ...